Recent Awards SetPoint Medical has recently received clinical research awards at prominent events like EULAR 2025 Congress. Highlighting these recognitions can enhance the company's credibility and competitiveness in the market, potentially attracting more interest from healthcare providers and stakeholders.

Tech Stack Utilization The company employs a modern tech stack including Amazon Web Services, Cloudflare, and iOS development. Leveraging these technologies to showcase innovative solutions and platform capabilities can create sales opportunities by demonstrating advanced functionality and reliability to potential clients.

Key Personnel Addition SetPoint Medical appointed a new member, Tyler Binney, to its Board of Directors. Utilizing this addition in sales pitches can emphasize the company's strategic leadership team, potentially instilling confidence in clients and partners regarding the company's vision and direction.

Financial Backing With recent investments totaling $80M in Series C equity, including funds from Viking Global Investors. This financial stability can be leveraged as a selling point to showcase confidence in the company's growth trajectory and product development, potentially attracting investors or strategic partners.

Positive Clinical Results SetPoint Medical announced positive results from the RESET-RA study, demonstrating the effectiveness of Neuroimmune modulation for treating Rheumatoid Arthritis. Sharing these success stories can generate sales leads by showcasing tangible outcomes and the potential benefits of the company's innovative treatment approach.